What is the recommended dosing regimen for fosphenytoin (phenytoin equivalents) in pediatric patients, including loading and maintenance doses, and what are the contraindications?

Fosphenytoin Pediatric Dosing

For pediatric status epilepticus, administer fosphenytoin at a loading dose of 15-20 mg PE/kg IV at a rate of 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower), followed by maintenance dosing of 4-8 mg PE/kg/day divided every 12 hours starting 12 hours after the loading dose. 1

Loading Dose Regimen

Status Epilepticus (Emergency Setting)

• Dose: 15-20 mg PE/kg IV
• Infusion rate: 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower) 1
• Maximum initial dose: 1000 mg 2
• Repeat dosing: May repeat once if necessary after 15 minutes (maximum total dose: 40 mg/kg) 2

The FDA label and AAP guidelines are aligned on this dosing, making this the most reliable recommendation 1, 2.

Non-Emergent Loading

• Dose: 10-15 mg PE/kg IV
• Infusion rate: 1-2 mg PE/kg/min (or 150 mg PE/min, whichever is slower) 1

Maintenance Dosing

Initial maintenance dose: 2-4 mg PE/kg given 12 hours after the loading dose 1

Subsequent maintenance: 4-8 mg PE/kg/day divided every 12 hours at a rate of 1-2 mg PE/kg/min (or 100 mg PE/min, whichever is slower) 1

Recent pharmacokinetic data supports starting maintenance dosing at 12 hours rather than 24 hours, with doses of 5-7.5 mg/kg every 12 hours appearing optimal to maintain therapeutic levels 3. This is more frequent than the traditional every-24-hour dosing and helps prevent subtherapeutic troughs.

Age-Specific Considerations

Neonates

• Loading dose: 10 mg/kg IV (lower than older children) 2
• Infusion time: 10-20 min; rate not to exceed 1 mg/kg/min 2
• Important caveat: Neonates have increased risk of toxicity due to decreased protein binding; phenobarbital is preferred over fosphenytoin in this age group 2

Infants <6 months

Recent evidence suggests that both 15 mg/kg and 20 mg/kg loading doses produce elevated free phenytoin concentrations (average 2.45-2.52 mg/L), with seizure cessation rates of 25-45% 4. The optimal dose in this population remains uncertain, but standard dosing (15-20 mg/kg) appears reasonable with close monitoring.

Route of Administration

Intramuscular administration should ordinarily NOT be used in pediatric patients 1. While IM fosphenytoin has been studied and may achieve therapeutic levels, IV administration is strongly preferred for:

• Status epilepticus (IM delays time to therapeutic levels) 1
• All pediatric patients when IV access is available 1

Monitoring and Timing

When to Check Levels

• First level: 2 hours after IV infusion completion (when conversion from fosphenytoin to phenytoin is essentially complete) 1
• Second level: 12 hours after loading dose to guide maintenance dosing 3
• Avoid checking levels: Before 2 hours post-IV or 4 hours post-IM, as immunoassays will overestimate phenytoin due to cross-reactivity with fosphenytoin 1

Target Concentrations

• Total phenytoin: 10-20 mcg/mL
• Free (unbound) phenytoin: 1-2 mcg/mL 1

Use EDTA tubes for blood collection before complete conversion to minimize ex vivo conversion of fosphenytoin to phenytoin 1.

Critical Safety Considerations

Cardiovascular Monitoring

• Continuous ECG monitoring is essential during infusion 1
• Monitor blood pressure and respiratory function throughout infusion 1
• Reduce infusion rate if heart rate decreases by 10 beats per minute 2
• Observe patient for 10-20 minutes after infusion ends (time of maximal serum concentrations) 1

Respiratory Precautions

• Increased risk of apnea when combined with benzodiazepines or other sedatives 2
• Be prepared to provide respiratory support 2
• Monitor oxygen saturation continuously 2

Common Pitfalls to Avoid

1. Do not use IM route in status epilepticus - therapeutic levels are not reached quickly enough 1
2. Do not check phenytoin levels too early - will be falsely elevated due to fosphenytoin cross-reactivity 1
3. Do not exceed maximum infusion rates - risk of hypotension and cardiac arrhythmias 1
4. Do not use phenytoin (not fosphenytoin) in glucose-containing solutions - causes precipitation 2

Advantages Over Phenytoin

Fosphenytoin is preferred over phenytoin when available because it has:

• Lower risk of adverse cardiac effects 2
• No risk of purple glove syndrome or tissue necrosis from extravasation
• Can be infused faster (3 mg PE/kg/min vs 1 mg/kg/min for phenytoin)
• Compatible with all IV solutions (phenytoin requires normal saline only) 2

Efficacy Expectations

Seizure control rates with fosphenytoin loading doses are approximately:

• 88% seizure cessation in general pediatric status epilepticus 5
• 36-64% control in severe malaria-associated status epilepticus 6
• May require additional 10 mg/kg dose if seizures persist 5

If fosphenytoin does not terminate seizures, use of other anticonvulsants should be considered 1. The drug should be followed immediately by a long-acting anticonvulsant for sustained effect 2.